Central Nervous Disorders

Sunovion prepares for FDA decision on Aptiom

Sunovion prepares for FDA decision on Aptiom

By

The FDA is expected to announce this week whether it has approved the epilepsy drug as a monotherapy for partial-onset seizures.

OPINION

Gottlieb Likely to Take On Off-Label, Predictability at the FDA

Newsletters